Effect of Terminology Used to Describe Medical Oncologists on Perceptions of Radiation Oncologists as Equal Partners in Cancer Care

by Malcolm D. Mattes, MD, Zachary White, II, MS, Daniel W. Golden, MD, MHPE, Neha Vapiwala, MD, Joseph M. Herman, MD, MS, MSHCM, FACR, Trevor J. Royce, MD, MS, MPH
Published 2021-01-01

Dose escalation for locally advanced pancreatic cancer: How high can we go?

by Lauren E. Colbert, MD, Neal Rebueno, CMD, Shalini Moningi, MD, Sam Beddar, PhD, Gabriel O. Sawakuchi, PhD, Joseph M. Herman, MD, Albert C. Koong, MD, PhD, Prajnan Das, MD, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2018-10-01

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers

by Kathryn J. Schunke, PhD, Lauren M. Rosati, BS, Marianna Zahurak, MS, Joseph M. Herman, MD, MSc, Amol K. Narang, MD, Irina Usach, Alison P. Klein, MHS, PhD, Charles J. Yeo, MD, Larry T. Korman, BSN, Ralph H. Hruban, MD, John L. Cameron, MD, Daniel A. Laheru, MD, Ross A. Abrams, MD
Published 2018-01-01

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer

by Shalini Moningi, MD, Jaffer A. Ajani, MD, Brian D. Badgwell, MD, Mariela B. Murphy, MD, Naruhiko Ikoma, MD, Paul F. Mansfield, MD, Jennifer C. Ho, MD, Yelin Suh, BS, Christopher Crane, MD, Joseph M. Herman, MD, Emma B. Holliday, MD, Eugene Koay, MD, PhD, Albert C. Koong, MD, PhD, Sunil Krishnan, MD, Bruce Minsky, MD, Grace Smith, MD, Cullen Taniguchi, MD, PhD, Prajnan Das, MD
Published 2020-05-01

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy

by Zhi Cheng, MD, MPH, Lauren M. Rosati, BS, Linda Chen, MD, Omar Y. Mian, MD, PhD, Yilin Cao, MD, Marta Villafania, BS, Minoru Nakatsugawa, PhD, Joseph A. Moore, PhD, Scott P. Robertson, PhD, Juan Jackson, BS, Amy Hacker-Prietz, PA-C, Jin He, MD, PhD, Christopher L. Wolfgang, MD, PhD, Matthew J. Weiss, MD, Joseph M. Herman, MD, MS, Amol K. Narang, MD, Todd R. McNutt, PhD
Published 2018-10-01

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

by Joseph Abi Jaoude, MD, Connor P. Thunshelle, BS, Ramez Kouzy, MD, Nicholas D. Nguyen, BA, Daniel Lin, BA, Laura Prakash, MD, Isabela M. Bumanlag, BS, Sonal S. Noticewala, MD, Joshua S. Niedzielski, PhD, Sam Beddar, PhD, Ethan B. Ludmir, MD, Emma B. Holliday, MD, Prajnan Das, MD, MS, MPH, Bruce D. Minsky, MD, Joseph M. Herman, MD, Matthew Katz, MD, Albert C. Koong, MD, PhD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-11-01

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

by Shalini Moningi, MD, Joseph Abi Jaoude, MD, Ramez Kouzy, MD, Daniel Lin, BA, Nicholas D. Nguyen, BA, Carolina J. Garcia Garcia, BS, Jae L. Phan, BA, Santiago Avila, BA, Daniel Smani, BA, Irina M. Cazacu, MD, Ben S. Singh, BA, Grace L. Smith, MD, PhD, MPH, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Prajnan Das, MD, MS, MPH, Manoop S. Bhutani, MD, Joseph M. Herman, MD, MSc, MSHM, Bruce D. Minsky, MD, Albert C. Koong, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-03-01